<DOC>
	<DOC>NCT00374725</DOC>
	<brief_summary>In this trial we test the hypothesis that a probiotic containing Lactobacillus acidophilus and Lactobacillus rhamnosus is an effective therapy for patients with ulcerative colitis.</brief_summary>
	<brief_title>Treatment of Ulcerative Colitis With a Combination of Lactobacillus Rhamnosus and Lactobacillus Acidophilus.</brief_title>
	<detailed_description>In the recent years there has been an increasing interest in the relationship between the gastrointestinal flora and gut function. Several studies have shown promising results for the use of probiotics in patient with inflammatory bowel disease. In this trial approximately 100 patients with ulcerative colitis will receive treatment with probiotic or placebo for 8 to 10 months as adjuvant therapy. The trial is double-blind, randomised and controlled.</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<criteria>Patients with known ulcerative colitis At least one prior flare of the disease Clinically and endoscopically active disease Age: 18 and above Changes in azathioprine dosage within the last three months Patients with toxic megacolon, peritoneal reaction or severe colonic bleeding Known immunodeficiencies Ongoing infectious disease Ongoing treatment with NSAID or cholestyramine Pregnant og lactating women</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2002</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Probiotic</keyword>
	<keyword>Placebo controlled trial</keyword>
	<keyword>Lactobacillus rhamnosus</keyword>
	<keyword>Lactobacillus acidophilus</keyword>
</DOC>